Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Pediatric Rheumatology
Published in: Pediatric Rheumatology 1/2019

Open Access 01-12-2019 | Juvenile Rheumatoid Arthritis | Research article

Retrospective review of immobilization vs. immediate resumption of activity in patients with Oligoarticular juvenile idiopathic arthritis following knee injections

Authors: Elaine R. Flanagan, Heather Benham, Janet Figueroa, Janille Diaz, Jenna Tress, David D. Sherry

Published in: Pediatric Rheumatology | Issue 1/2019

Login to get access

Abstract

Background

Intraarticular corticosteroid injection (IACI) is one of the most common treatments in oligoarticular Juvenile Idiopathic Arthritis (JIA). Activity recommendations following injection vary, as there are no published studies on splinting JIA patients post-IACI (splinting is a form of rest). Texas Scottish Rite Hospital for Children (TSRH) splints patients post-IACI for 24 h while The Children’s Hospital of Philadelphia (CHOP) does not. The aim of this study was to compare the number of cases of recurrent arthritis following IACI between these two post-injection practices.

Methods

Data were retrospectively collected at CHOP and TSRH. Patients diagnosed with oligoarticular JIA according to International League of Associations for Rheumatology (ILAR) criteria (2nd revision, 2001) between 2008 and 2010 were included. Bivariate analysis (Wilcoxon rank-sum tests, chi-squared tests) was run to assess differences in outcomes by site. Inverse probability of treatment weighted Cox regression was employed to adjust for site differences.

Results

The population at TSRH was younger than at CHOP (p < 0.05) and had more whites (p = 0.03). Disease duration was significantly longer at TSRH than at CHOP (0.40 vs. 0.74 years, p = 0.014). More children were on biologics at the time of injection at CHOP (p < 0.05). The baseline physician global (p < 0.001) was higher at CHOP, as was the joint disease severity (p < 0.001). CHOP had fewer reoccurrences of knee arthritis compared to TSRH: 26% vs 38% (p = 0.14).

Conclusions

The baseline populations were different in that the TSRH group had more whites and Hispanics, were younger and, perhaps, had less severe disease than CHOP. Patients treated with post-injection splinting had a trend toward more arthritis reoccurrence (38% vs. 26%, p = 0.14). Splinting is not clearly beneficial post-injection.

Trial registration

This is an observational study, so it is not applicable.
Appendix
Available only for authorised users
Literature
1.
Petty RE, Southwood R, Manners P, Baum J, Glass DN, Goldenberg J, et al. International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390–2.PubMed
2.
Petty RE, Laxer RM, Lindsley CB, Wedderburn LR. Oligoarticular juvenile idiopathic arthritis. In: Petty RE, Lindsley CB, editors. Textbook of pediatric rheumatology. Philadelphia: Elsevier; 2016. p. 229–37.CrossRef
3.
Cron RQ, Sharma S, Sherry DD. Current treatment by United States and Canadian pediatric rheumatologists. J Rheumatol. 1999;26:2036–8.PubMed
4.
Cleary AG, Murphy HD, Davidson JE. Intra-articular corticosteroid injections in juvenile arthritis. Arch Dis Child. 2003;88:192–6.CrossRef
5.
Hashkes PJ, Laxer RM. Medical treatment of juvenile idiopathic arthritis. JAMA. 2005;294:1671–84.CrossRef
6.
Padeh S, Passwell JH. Intraarticular corticosteroid injection in the management of children with chronic arthritis. Arthritis Rheum. 1998;41:1210–4.CrossRef
7.
Sherry DD, Stein LD, Reed AM, Schanberg LE, Kredich DW. Prevention of leg length discrepancy in young children with pauciarticular juvenile rheumatoid arthritis by treatment with intraarticular steroids. Arthritis Rheum. 1999;42:2330–4.CrossRef
8.
Papadopoulou C, Kostik M, Gonzalez-Fernandez MI, Bohm M, Nieto-Gonzalez JC, et al. Delineating the role of multiple intraarticular corticosteroid injections in the management of juvenile idiopathic arthritis in the biologic era. Arthritis Care Res. 2012;65(7):1112–20.CrossRef
9.
Hertzberger-ten CR. de Vries-van der Vlugt BCM, van Suijlekom-smit LWA, cats a. intra-articular steroids in pauciarticular juvenile chronic arthritis, type I. Eur J Pediatr. 1991;150:170–2.CrossRef
10.
Ravelli A, Manzoni SM, Viola S, Pistoria A, Ruperto N, Martini A. Factors affecting the efficacy of intraarticular corticosteroid injections of knees in juvenile idiopathic arthritis. J Rheumatol. 2001;28:2100–2.PubMed
11.
Lepore L, Del Santo M, Malorgio C, Presani G, Perticarari S, Prodan M, et al. Treatment of juvenile idiopathic arthritis with intra-articular triamcinolone hexacetonide: evaluation of clinical effectiveness correlated with circulating ANA and T γ/δ+ and B CD5+ lymphocyte populations of synovial fluid. Clin Exp Rheumatol. 2002;20:719–22.PubMed
12.
Gotte AC. Intra-articular corticosteroids in the treatment of juvenile idiopathic arthritis: safety, efficacy, and features affecting outcome. A comprehensive review of the literature. Open Access Rheumatol. 2009;1:37–49.CrossRef
13.
Verma W, Gupta R, Lodha R, Kabra SK. Feasibility and efficacy of intraarticular steroids (IAS) in juvenile idiopathic arthritis (JIA). Indian Pediatr. 2009;46:264–5.PubMed
14.
Honkanen VEA, Rautonen JK, Pelkonen PM. Intra-articular glucocorticoids in early juvenile idiopathic arthritis. Acta Paediatr. 1993;82:1072–4.CrossRef
15.
Unsal E, Makay B. Intra-articular triamcinolone in juvenile idiopathic arthritis. Indian Pediatr. 2008;45:995–7.PubMed
16.
Eberhard BA, Sison MC, Gottlieb BS, Ilowite NT. Comparison of the intraarticular effectiveness of triamcinolone hexacetonide and triamcinolone acetonide in treatment of juvenile rheumatoid arthritis. J Rheumatol. 2004;31:2507–12.PubMed
17.
Breit W, Frosch M, Meyer U, Heinecke A, Ganser G. A subgroup-specific evaluation of the efficacy of intra-articular triamcinolone hexacetonide ion juvenile chronic arthritis. J Rheumatol. 2007;27:2696–702.
18.
Zulian F, Martini G, Gobber D, Agosto C, Gigante C, Zacchello F. Comparison of intra-articular triamcinolone hexacetonide and triamcinolone acetonide in oligoarticular juvenile idiopathic arthritis. Rheumatology. 2003;42:1254–9.CrossRef
19.
Zulian F, Martini G, Gobber D, Plebani M, Zacchello F, Manners P. Triamcinolone acetonide and hexacetonide intra-articular treatment of symmetrical joints in juvenile idiopathic arthritis: a double-blind trial. Rheumatology. 2004;43:1288–91.CrossRef
20.
Allen RC, Gross KC, Laxer RM, Malleson PN, Beauchamp RD, Petty RE. Intraarticular triamcinolone hexacetonide in the management of chronic arthritis in children. Arthritis Rheum. 1986;29:997–1001.CrossRef
21.
McCarty DJ, Harman JG, Grassanovich JL, Qian C. Treatment of rheumatoid joint inflammation with intrasynovial triamcinolone hexacetonide. J Rheumatol. 1995;22:1631–5.PubMed
22.
Winfield J, Crawley JCW, Hudson EA, Fisher M, Gumpel JM. Evaluation of two regimens to immobilize the knee after injections of yttrium-90. BrMed J. 1979;1:986–7.
23.
Neustadt DH. Letter to the editor: rest regimen after intraarticular corticosteroid treatment. Arthritis Care Res. 1990;3:103–4.PubMed
24.
Neustadt DH. Letter to the editor: treatment of rheumatoid joint inflammation with intrasynovial triamcinolone. J Rheumatol. 1996;23:1666–7.PubMed
25.
Neustadt DH. Intra-articular therapy for rheumatoid synovitis of the knee: effects of the post injection rest regimen. Best Pract Res Clin Rheumatol. 1985;3:65–8.
26.
Chakravarty K, Pharoah PDP, Scott DGI. A randomized controlled study of post-injection rest following intra-articular steroid therapy for knee synovitis. Br J Rheumatol. 1994;33:464–8.CrossRef
27.
Weitoft T, Larsson A, Saxne T, Ronnblom L. Changes of cartilage and bone markers after intra-articular glucocorticoid treatment with and without postinjection rest in patients with rheumatoid arthritis. Ann Rheum Dis. 2005;64:1750–3.CrossRef
28.
Weitoft T, Ronnblom L. Randomised controlled study of postinjection immobilization after intra-articular glucocorticoid treatment for wrist synovitis. Ann Rheum Dis. 2003;62:1013–5.CrossRef
29.
Wietoft T, Forsberg C. Importance of immobilization after intraarticular glucocorticoid treatment for elbow synovitis: a randomized controlled study. Arthritis Care Res. 2010;62:735–7.CrossRef
30.
Wallace CA1, Ruperto N, Giannini E; Childhood arthritis and rheumatology research Alliance; pediatric rheumatology international trials organization; pediatric rheumatology collaborative study group. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol 2004;31:2290–2294.
31.
32.
Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med. 2015;34:3661–79.CrossRef
33.
34.
Camacho-Gonzalez AF, Gillespie SE, Thomas-Seaton L, Frieson K, Hussen SA, Murray A, et al. The metropolitan Atlanta community adolescent rapid testing initiative study: closing the gaps in HIV care among youth in Atlanta, GA. AIDS. 2017;31(Suppl 3):S267–75.CrossRef
35.
Luzia Garcia Cunha A. Bugni Miotto e Silva V, Osaku FM, Niemxeski, LB, Furtado, RN, Natour, J, et al. intra-articular injection in patients with juvenile idiopathic arthritis: factors associated with a good response. Rev Bras Rheumatol. 2016;56:490–6.CrossRef
36.
Bloom BJ, Alario AJ, Miller LC. Intra-articular corticosteroid therapy for juvenile idiopathic arthritis: report of an experiential cohort and literature review. Rheumatol Int. 2011;31:749–56.CrossRef
37.
Eberhard BA, Ilowite NT, Sison C. A dose schedule for intraarticular steroids in juvenile arthritis. J Rheumatol. 2012;39:374–6.CrossRef
Metadata
Title
Retrospective review of immobilization vs. immediate resumption of activity in patients with Oligoarticular juvenile idiopathic arthritis following knee injections
Authors
Elaine R. Flanagan
Heather Benham
Janet Figueroa
Janille Diaz
Jenna Tress
David D. Sherry
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Pediatric Rheumatology / Issue 1/2019
Electronic ISSN: 1546-0096
DOI
https://doi.org/10.1186/s12969-019-0339-0

Other articles of this Issue 1/2019

Pediatric Rheumatology 1/2019 Go to the issue

Review

Scoping review of biological treatment of deficiency of interleukin-36 receptor antagonist (DITRA) in children and adolescents

Research article

The pain trajectory of juvenile idiopathic arthritis (JIA): translating from adolescent patient report to behavioural sensitivity in a juvenile animal model

Research article

Effectiveness of long-term infliximab use and impact of treatment adherence on disease control in refractory, non-infectious pediatric uveitis

Research article

No radiographic wrist damage after treatment to target in recent-onset juvenile idiopathic arthritis

Review

Hallmark trials in ANCA-associated vasculitis (AAV) for the pediatric rheumatologist

Research article

Participation in school sports among children and adolescents with juvenile idiopathic arthritis in the German National Paediatric Rheumatologic Database, 2000–2015: results from a prospective observational cohort study